News
4d
GlobalData on MSNCTO East Coast 2025: Navigating shifting regulatory environment hinges on close alignmentIn a more challenging regulatory environment for clinical trials, optimising trial designs early makes success more likely.
2d
Clinical Trials Arena on MSNAdapting to funding and operational hurdles in today’s clinical trials landscapeUK & Ireland, experts provided insights on market trends within the clinical trial industry and advice on engagement strategies.
Outdated regulations and inflexible sponsor processes are hampering clinical trial recruitment, but empowering sites with ...
Responding to the European Commission’s call for evidence, Biovia says regulatory delays, fragmented markets, and lack of ...
The EU’s health commissioner says there’s “no time to lose” as he lays out a raft of plans in the Life Sciences Strategy for ...
Chinese drugmaker Innogen expects to complete a late-stage clinical trial of its experimental weight-loss drug candidate next ...
Secured approval from the Regulation Agency for Medical and Pharmaceutical Activities (RAMPA) in Georgia for Phase 2B/3 ...
Medically accredited supplement gains national traction with expert-backed multi-action formula and user trust.
In a functioning system, the kind of placebo-controlled vaccine trials that Secretary Kennedy is calling for would never get ...
This article discusses the complexities and challenges of transitioning clinical trials to comply with the EU Clinical Trial Regulation (CTR), offering insights and guidance to ensure a smooth ...
Chia seeds vs. Flaxseeds: Which superfood is truly better for you?
Professor Andrea Manfrin joined the MHRA in June 2023 as Deputy Director of Clinical Investigations and Trials, to spearhead the regulator’s overhaul of the clinical trial regulations. His ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results